Literature DB >> 21616096

Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.

Eun Hui Bae1, Seong Kwon Ma, Jongun Lee, Soo Wan Kim.   

Abstract

The present study was aimed to determine whether there is an altered role of local nitric oxide (NO) and atrial natriuretic peptide (ANP) systems in the kidney in association with the angiotensin (Ang) II-induced hypertension. Male Sprague-Dawley rats were used. Ang II (100 ng·min⁻¹·kg⁻¹) was infused through entire time course. Thirteenth day after beginning the regimen, kidneys were taken. The protein expression of NO synthase (NOS) and nitrotyrosine was determined by semiquantitative immunoblotting. The mRNA expression of components of ANP system was determined by real-time polymerase chain reaction. The activities of soluble and particulate guanylyl cyclases were determined by the amount of cGMP generated in responses to sodium nitroprusside and ANP, respectively. There developed hypertension and decreased creatinine clearance in the experimental group. The protein expression of eNOS, nNOS and nitrotyrosine was increased in the cortex, while that of iNOS remained unaltered. The urinary excretion of NO increased in Ang II-induced hypertensive rats. The catalytic activity of soluble guanylyl cyclase was blunted in the glomerulus in Ang II-induced hypertensive rats. The mRNA expression of ANP was increased in Ang II-induced hypertensive rats. Neither the expression of NPR-A nor that of NPR-C was changed. The protein expression of neutral endopeptidase was decreased and the activity of particulate guanylyl cyclase was blunted in the glomerulus and papilla in Ang II-induced hypertensive rats. In conclusion, the synthesis of NO and ANP was increased in the kidney of Ang II-induced hypertension, while stimulated cGMP response was blunted. These results suggest desensitization of guanylyl cyclase in the kidney of Ang II-induced hypertensive rats, which may contribute to the associated renal vasoconstriction and hypertension.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21616096     DOI: 10.1016/j.regpep.2011.05.005

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  10 in total

1.  Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.

Authors:  Saumya Ramanathan; Stacy Mazzalupo; Scott Boitano; William R Montfort
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

2.  Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.

Authors:  Pierre-Antoine Crassous; Samba Couloubaly; Can Huang; Zongmin Zhou; Padmamalini Baskaran; David D Kim; Andreas Papapetropoulos; Xavier Fioramonti; Walter N Durán; Annie Beuve
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

3.  Endothelium-derived nitric oxide supports renin cell recruitment through the nitric oxide-sensitive guanylate cyclase pathway.

Authors:  Björn Neubauer; Katharina Machura; Ramona Kettl; Maria Luisa S Sequeira Lopez; Andreas Friebe; Armin Kurtz
Journal:  Hypertension       Date:  2013-01-07       Impact factor: 10.190

4.  Angiotensin II-mediated hypertension impairs nitric oxide-induced NKCC2 inhibition in thick ascending limbs.

Authors:  Vanesa D Ramseyer; Pablo A Ortiz; Oscar A Carretero; Jeffrey L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-17

Review 5.  Altered Nitric Oxide System in Cardiovascular and Renal Diseases.

Authors:  JongUn Lee; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Chonnam Med J       Date:  2016-05-20

Review 6.  Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy.

Authors:  Javier Díez
Journal:  Eur J Heart Fail       Date:  2016-10-21       Impact factor: 15.534

Review 7.  The Endocrine Function of the Heart: Physiology and Involvements of Natriuretic Peptides and Cyclic Nucleotide Phosphodiesterases in Heart Failure.

Authors:  Claire Lugnier; Alain Meyer; Anne Charloux; Emmanuel Andrès; Bernard Gény; Samy Talha
Journal:  J Clin Med       Date:  2019-10-21       Impact factor: 4.241

Review 8.  Cellular and Molecular Mechanism of Traditional Chinese Medicine on Ventricular Remodeling.

Authors:  Yong-Chun Zhu; Bo Liang; Ning Gu
Journal:  Front Cardiovasc Med       Date:  2021-12-01

Review 9.  The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.

Authors:  Massimo Volpe; Marino Carnovali; Vittoria Mastromarino
Journal:  Clin Sci (Lond)       Date:  2016-01       Impact factor: 6.124

Review 10.  Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.

Authors:  Shihui Fu; Ping Ping; Fengqi Wang; Leiming Luo
Journal:  J Biol Eng       Date:  2018-01-12       Impact factor: 4.355

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.